Oscar Health (NYSE:OSCR) Price Target Cut to $45.00 by Analysts at Piper Sandler

Oscar Health (NYSE:OSCR) had its price objective cut by Piper Sandler from $48.00 to $45.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the stock.

OSCR has been the topic of a number of other reports. Robert W. Baird increased their price objective on Oscar Health from $27.00 to $33.00 and gave the company a “neutral” rating in a report on Thursday, September 17th. Raymond James Financial upped their price target on shares of Oscar Health from $34.00 to $42.00 and gave the stock an “outperform” rating in a research report on Friday, September 18th. Bank of America boosted their price target on shares of Oscar Health from $28.00 to $30.00 and gave the stock an “underperform” rating in a research report on Thursday, September 17th. Barclays boosted their price target on shares of Oscar Health from $39.00 to $49.00 and gave the company an “overweight” rating in a research report on Thursday, September 17th. Finally, The Goldman Sachs Group restated a “neutral” rating and set a $34.00 price target on shares of Oscar Health in a report on Thursday, September 17th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $34.60.

Oscar Health Trading Down 7.3%

OSCR stock traded down $2.44 during midday trading on Friday, reaching $30.74. The company’s stock had a trading volume of 8,874,950 shares, compared to its average volume of 4,643,670. The firm has a market capitalization of $9.49 billion, a price-to-earnings ratio of 12.70, a PEG ratio of 0.34 and a beta of 2.56. The stock has a fifty day simple moving average of $31.81 and a two-hundred day simple moving average of $23.97. Oscar Health has a 1 year low of $10.69 and a 1 year high of $38.50. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 5th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.63. The business had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $4.69 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company’s revenue for the quarter was up 72.1% on a year-over-year basis. During the same quarter last year, the firm posted ($0.53) EPS. On average, equities research analysts predict that Oscar Health will post 1.83 EPS for the current year.

Insider Buying and Selling at Oscar Health

In related news, insider Adam Mcananey sold 9,092 shares of Oscar Health stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total value of $285,943.40. Following the completion of the transaction, the insider directly owned 209,004 shares in the company, valued at approximately $6,573,175.80. This trade represents a 4.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Vanessa Wittman sold 25,000 shares of Oscar Health stock in a transaction on Friday, September 18th. The shares were sold at an average price of $32.24, for a total value of $806,000.00. Following the completion of the transaction, the director owned 112,121 shares of the company’s stock, valued at approximately $3,614,781.04. This trade represents a 18.23% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 874,451 shares of company stock valued at $26,761,671. Insiders own 22.64% of the company’s stock.

Institutional Investors Weigh In On Oscar Health

Several large investors have recently bought and sold shares of OSCR. Diversified Trust Co purchased a new position in shares of Oscar Health in the 3rd quarter valued at about $374,000. Russell Investments Group Ltd. raised its position in shares of Oscar Health by 62.5% during the 3rd quarter. Russell Investments Group Ltd. now owns 868,194 shares of the company’s stock worth $26,775,000 after acquiring an additional 333,785 shares in the last quarter. Fifth Third Bancorp lifted its stake in Oscar Health by 67.9% during the third quarter. Fifth Third Bancorp now owns 152,121 shares of the company’s stock worth $4,691,000 after purchasing an additional 61,544 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its stake in Oscar Health by 4.4% during the third quarter. Allspring Global Investments Holdings LLC now owns 31,941 shares of the company’s stock worth $955,000 after purchasing an additional 1,339 shares during the last quarter. Finally, Alps Advisors Inc. purchased a new stake in Oscar Health during the third quarter worth approximately $529,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Key Oscar Health News

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: Oscar reported Q3 adjusted earnings of $0.49 per share, versus analysts’ expected loss, and revenue of $5.14 billion, topping the $4.69 billion estimate and rising 72.1% year over year. Oscar Health beats Q3 earnings and revenue estimates
• Positive Sentiment: The company raised its 2026 revenue outlook to $19 billion–$19.3 billion, above the $18.64 billion FactSet estimate, and increased its full-year earnings outlook. Management cited improving medical costs and operating efficiencies as supporting margin gains, with expansion expected to contribute to 2027 growth. Q3 earnings call highlights outlook and margin gains
• Positive Sentiment: Operational indicators were also encouraging: membership increased 27.2% to 2.69 million, the medical loss ratio improved to 84.0%, and Oscar swung to a $167.3 million profit. Oscar Health Q3 revenue and membership growth
• Positive Sentiment: Zacks added OSCR to its Rank #1 (Strong Buy) growth-stocks list, reflecting favorable quantitative signals. Zacks growth stocks list
• Negative Sentiment: Piper Sandler lowered its price target from $48 to $45, although it maintained an Overweight rating. The new target still implies substantial upside from the referenced $30.74 share price. Piper Sandler rating information

Oscar Health Company Profile

Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.

Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.